Last reviewed · How we verify
NCT05073991
Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
trial testing Lung surgery in Morality in 2,224 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Mahidol University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,224 |
| Start date | 23 October 2021 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Lung surgery
- Open aortic surgery
- TEVAR
- EVAR
Conditions studied
- Morality — all drugs for Morality →
- Lung Cancer — all drugs for Lung Cancer →
- Aortic Aneurysm — all drugs for Aortic Aneurysm →
- Aortic Dissection — all drugs for Aortic Dissection →
Sponsor
Mahidol University
Who can join
18 and older, any sex, with Morality or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lung surgery, open aortic surgery, TEVAR, and EVAR are major operations that carry a higher incidence of perioperative mortality and complications compare to other surgery. The study of the incidence of mortality and complications will help the hospital to benchmark with the others. Also the study of the risk factors of mortality and major complications will help to improve the patients' outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05073991
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lung surgery
Trials testing the same drug.
- NCT02928003 — Chronic Neuropathic Pain After Lung Surgery: Prevalence and Predictive Factors · NA · completed
Other recruiting trials for Morality
Currently open trials in the same condition.
- NCT07187596 — Mortality Outcome of Controlled Hypertension · active not recruiting
- NCT07009847 — An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine · recruiting
- NCT06570759 — Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI · NA · active not recruiting
- NCT06452966 — The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients · NA · recruiting
- NCT06420479 — The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality · recruiting
Other Mahidol University trials
Trials by the same sponsor.
- NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
- NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
- NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
- NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
- NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05073991 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mahidol University
- Last refreshed: 1 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05073991.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing